{"id":487,"date":"2026-06-07T13:33:37","date_gmt":"2026-06-07T13:33:37","guid":{"rendered":"https:\/\/titanbornresearch.com\/?p=487"},"modified":"2026-06-07T14:15:04","modified_gmt":"2026-06-07T14:15:04","slug":"what-is-selank-a-researchers-guide-to-the-calming-russian-peptide","status":"publish","type":"post","link":"https:\/\/titanbornlabs.com\/?p=487","title":{"rendered":"What Is Selank? A Researcher’s Guide to the Calming Russian Peptide"},"content":{"rendered":"\n
\n\"Selank\n\n

\/\/ Cognitive \u00b7 Compound Profile \u00b7 Research Education \u00b7 Titanborn Research<\/p>\n\n

\n

\/\/ Educational & Research Use Only<\/p>\n

This article summarizes published scientific literature. It is not medical advice and is not intended to promote or describe human use. All Titanborn Research products are for laboratory research only.<\/p>\n<\/div>\n\n

Selank is the calm to Semax’s focus. They came out of the same Moscow laboratory, share the same clever stabilization trick, and are studied together so often the research community calls them “sister peptides.” But where Semax was engineered from a hormone fragment to sharpen cognition, Selank was engineered from an immune peptide \u2014 and its standout reported property is something no Western anxiety drug achieves cleanly: anxiety reduction comparable to benzodiazepines, reportedly without the sedation, cognitive fog, or dependence.<\/p>\n\n

Like Semax, Selank carries a real Russian clinical history and the same catch \u2014 most of the human evidence is Russian and hasn’t been replicated in large Western trials. This guide covers what it is, its surprising immune-system origin, how it works, what the research shows, and how it pairs with Semax.<\/p>\n\n

What Selank Actually Is<\/h2>\n

A synthetic heptapeptide<\/strong> \u2014 seven amino acids, sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP).<\/p>\n

Built from an immune peptide, not a brain hormone.<\/strong> This is the surprising part: Selank is a synthetic analog of tuftsin, a naturally occurring tetrapeptide (Thr-Lys-Pro-Arg) cleaved from the heavy chain of immunoglobulin G (IgG) \u2014 an antibody. Tuftsin’s natural job is immune: it stimulates phagocytosis and activates macrophages and neutrophils.<\/p>\n

The same Pro-Gly-Pro trick as Semax.<\/strong> Russian researchers added a Pro-Gly-Pro tail to tuftsin’s C-terminus. This did two things: increased metabolic stability (protecting it from rapid enzymatic breakdown), and \u2014 remarkably \u2014 shifted the activity from primarily immune-stimulating toward neuromodulatory. The result kept some immune properties but gained the anxiolytic and nootropic effects Selank is known for.<\/p>\n

Also designated TP-7<\/strong>; “Selank” is its approved drug name in Russia.<\/p>\n

Made synthetically<\/strong> for research and (in Russia) clinical use, typically as an intranasal solution.<\/p>\n

Notice the shared engineering signature with Semax: both take a natural short peptide and bolt on a Pro-Gly-Pro tail for stability. That’s the fingerprint of the same research program.<\/p>\n\n

Where It Came From: The Same Lab as Semax<\/h2>\n

Selank’s origin runs directly parallel to Semax’s \u2014 by design:<\/p>\n

It was developed (in the 1990s) at the Institute of Molecular Genetics of the Russian Academy of Sciences<\/strong> in Moscow \u2014 the same institute that produced Semax \u2014 in cooperation with the V.V. Zakusov Research Institute of Pharmacology.<\/p>\n

The starting material, tuftsin, is a well-characterized immune tetrapeptide. Russian researchers took that molecule and engineered the more stable, brain-active Selank from it, in the same Russian neuropeptide research tradition associated with Semax. Like Semax, Selank was eventually approved in Russia \u2014 in its case for generalized anxiety disorder and neurasthenia.<\/p>\n

So the two peptides aren’t just thematically similar \u2014 they’re institutional siblings from one Russian neuropeptide program, which is exactly why they’re studied and discussed as a pair.<\/p>\n\n

How It Works<\/h2>\n\"GABA\n

Selank’s mechanism is multi-target, and the headline is its GABA effect:<\/p>\n

GABA system modulation (the anxiolytic engine).<\/strong> Clinical studies reported Selank’s anxiolytic effect comparable to classical benzodiazepines, which work by enhancing GABA’s inhibitory signaling. Gene-expression studies show Selank affects genes involved in GABAergic neurotransmission, suggesting it acts in part through the GABAergic system.<\/p>\n

The crucial difference from benzodiazepines:<\/strong> Selank’s defining reported feature is anxiolysis without sedation, cognitive impairment, or dependence \u2014 a combination Western benzodiazepines don’t achieve cleanly (they typically sedate and carry dependence risk).<\/p>\n

Enkephalin stabilization.<\/strong> Selank inhibits the breakdown of enkephalins (the body’s own opioid-like signaling molecules), prolonging their activity \u2014 proposed as part of its calming and mood effects.<\/p>\n

BDNF upregulation.<\/strong> Like Semax, Selank influences brain-derived neurotrophic factor \u2014 the overlap that gives both peptides a nootropic\/neuroprotective dimension.<\/p>\n

Immune modulation (its tuftsin heritage).<\/strong> It retains immune effects \u2014 research shows it may modulate cytokines such as IL-6 and influence T-helper-cell balance in animal models, appearing to normalize immune function rather than broadly suppress or stimulate it.<\/p>\n

Benzodiazepine interaction.<\/strong> Notably, one rat study found Selank can enhance the effect of diazepam \u2014 a mechanistically interesting finding.<\/p>\n

The contrast with Semax writes itself: Semax pushes cognition up (BDNF + dopaminergic\/stimulating); Selank brings anxiety down (GABA + calming) \u2014 without sedating. Both touch BDNF, which is the shared thread. Accelerator and brake, from the same garage.<\/p>\n\n

What the Research Shows \u2014 and the Honest Catch<\/h2>\n

Selank’s evidence profile closely mirrors Semax’s, with the same strengths and the same limitation:<\/p>\n

The real clinical footprint (in Russia):<\/strong> Selank is approved in Russia for generalized anxiety disorder and used as a nootropic \u2014 a genuine clinical adoption, not just a lab curiosity. Clinical studies reported anxiolytic effects comparable to benzodiazepines, and decades of preclinical and early clinical research cover anxiety, stress response, memory\/learning, and immune modulation.<\/p>\n

The honest catch (same as Semax):<\/strong><\/p>\n

The clinical evidence is overwhelmingly Russian. As with Semax, the human trial data is concentrated in Russian-language research and has not been replicated in large Western randomized controlled trials.<\/p>\n

Much of the mechanistic data is preclinical \u2014 animal models and cell cultures. The anxiolytic-vs-benzodiazepine comparisons, the immune effects, and the BDNF findings draw heavily on rats and lab models, and do not by themselves constitute verified therapeutic actions in humans.<\/p>\n

No FDA or EMA approval \u2014 like Semax, it’s regulatorily invisible in the West. And the clean “no sedation, no dependence” profile, while a genuine selling point in the Russian literature, has limited rigorous independent Western confirmation.<\/p>\n

The fair framing, identical in shape to Semax: a real registered medicine somewhere, with an unusually clean reported profile and solid mechanistic science \u2014 but the independent Western confirmation that would settle it hasn’t been done.<\/p>\n\n

The Regulatory Picture (As of Mid-2026)<\/h2>\n

Not FDA- or EMA-approved.<\/strong><\/p>\n

An approved medicine in Russia<\/strong> for generalized anxiety disorder and as a nootropic.<\/p>\n

An earlier chapter of the FDA peptide story than its siblings.<\/strong> Here’s a distinction worth getting right, because it sets Selank apart from BPC-157, TB-500, and Semax. Selank acetate (TP-7) was one of five peptides \u2014 alongside AOD-9604, CJC-1295, ipamorelin, and thymosin alpha-1 \u2014 removed from Category 2 back on September 27, 2024 (its nomination withdrawn), well ahead of the bigger April 2026 reversal. It was then referred to the FDA’s Pharmacy Compounding Advisory Committee and reviewed in late 2024 \u2014 but unlike the peptides on the July 2026 docket, Selank’s path to the 503A bulks list did not clear at that review. So Selank sits in a more uncertain, already-reviewed limbo rather than riding the fresh 2026 momentum.<\/p>\n\n

\n

\/\/ Go Deeper<\/p>\n

For the full story of how peptides ended up restricted \u2014 and how the 2026 reversal unfolded across the category \u2014 see our companion article: Who Really Put Peptides on the Restricted List →<\/a><\/p>\n<\/div>\n\n

For a research-use-only context: Selank is supplied for laboratory research, not human use \u2014 and its approval status in Russia does not change its U.S. legal standing.<\/p>\n\n

Where the Research May Be Heading<\/h2>\n

The replication gap is the headline frontier<\/strong> \u2014 exactly as with Semax. Independent Western trials confirming the benzodiazepine-comparable anxiolytic effect (and the clean safety profile) would be transformative for how seriously Selank is taken globally.<\/p>\n

Neurodegenerative disease.<\/strong> A 2020 review (Shadrina et al.) explicitly framed Selank’s prospects for anxiety disorders and neurodegenerative diseases \u2014 an expanding scope.<\/p>\n

The benzodiazepine-interaction finding<\/strong> (enhancing diazepam’s effect) is mechanistically intriguing and a live research thread.<\/p>\n

The immune-neuro crossover.<\/strong> Because it descends from an immune peptide but acts on the brain, Selank sits at an interesting intersection that researchers continue to probe.<\/p>\n\n

Why Purity and Identity Testing Matter for Selank Specifically<\/h2>\n

It’s a precise seven-amino-acid sequence (TKPRPGP).<\/strong> As with any defined peptide, a synthesis error or truncation yields a different molecule. Only mass-spec identity testing confirms the exact sequence is present.<\/p>\n

Tuftsin-related impurities are a relevant consideration<\/strong> \u2014 since Selank is built on the tuftsin fragment, confirming you have the full stabilized heptapeptide (not tuftsin or a partial sequence) matters for research validity.<\/p>\n

Unregulated supply puts verification on the buyer.<\/strong> Like every research peptide outside formal oversight, a third-party Certificate of Analysis confirming identity and purity is the dividing line between defined research material and an assumption.<\/p>\n\n

\n

\/\/ Titanborn Standard<\/p>\n

Semax’s calming sister \u2014 same lab, same engineering, opposite effect \u2014 with a genuinely intriguing clean-anxiolytic profile that the rigorous Western trials haven’t yet confirmed. 99%+ purity. ISO 17025 independent testing. Batch-specific COA. QR-verified live results. Every order. 99%+ or Nothing.<\/p>\n<\/div>\n\n

\n

\/\/ Related Reading<\/p>\n

What Is Semax? →<\/a> \u2014 Selank’s cognitive counterpart from the same Moscow lab<\/span><\/p>\n

Who Really Put Peptides on the Restricted List →<\/a> \u2014 the full FDA regulatory story<\/span><\/p>\n<\/div>\n\n

\n

This article is for educational and research purposes only \u00b7 Not medical advice \u00b7 Sources include peer-reviewed literature and regulatory filings \u00b7 Russian clinical data noted as geographically concentrated and not independently replicated in the West \u00b7 All Titanborn Research products are for research use only \u00b7 Not for human consumption \u00b7 Not for veterinary use \u00b7 titanbornresearch.com<\/p>\n<\/div>\n\n<\/div>\n","protected":false},"excerpt":{"rendered":"

\/\/ Cognitive \u00b7 Compound Profile \u00b7 Research Education \u00b7 Titanborn Research \/\/ Educational & Research Use Only This article summarizes published scientific literature. It is not medical advice and is not intended to promote or describe human use. All Titanborn Research products are for laboratory research only. Selank is the calm to Semax’s focus. They…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[202],"tags":[209,211,212,23,208,210],"class_list":["post-487","post","type-post","status-publish","format-standard","hentry","category-cognitive","tag-anxiolytic","tag-gaba","tag-peptides","tag-research-peptides","tag-selank","tag-tuftsin"],"acf":[],"taxonomy_info":{"category":[{"value":202,"label":"Cognitive"}],"post_tag":[{"value":209,"label":"anxiolytic"},{"value":211,"label":"GABA"},{"value":212,"label":"peptides"},{"value":23,"label":"research peptides"},{"value":208,"label":"Selank"},{"value":210,"label":"tuftsin"}]},"featured_image_src_large":false,"author_info":{"display_name":"TitanBorn Research","author_link":"https:\/\/titanbornlabs.com\/author\/root"},"comment_info":0,"category_info":[{"term_id":202,"name":"Cognitive","slug":"cognitive","term_group":0,"term_taxonomy_id":202,"taxonomy":"category","description":"Nootropic and neuroactive research peptides studied for cognition, focus, mood, and neuroprotection \u2014 including Semax and Selank. Clear, sourced explanations of the science and the open questions. For research use only.","parent":0,"count":2,"filter":"raw","cat_ID":202,"category_count":2,"category_description":"Nootropic and neuroactive research peptides studied for cognition, focus, mood, and neuroprotection \u2014 including Semax and Selank. Clear, sourced explanations of the science and the open questions. For research use only.","cat_name":"Cognitive","category_nicename":"cognitive","category_parent":0}],"tag_info":[{"term_id":209,"name":"anxiolytic","slug":"anxiolytic","term_group":0,"term_taxonomy_id":209,"taxonomy":"post_tag","description":"","parent":0,"count":1,"filter":"raw"},{"term_id":211,"name":"GABA","slug":"gaba","term_group":0,"term_taxonomy_id":211,"taxonomy":"post_tag","description":"","parent":0,"count":1,"filter":"raw"},{"term_id":212,"name":"peptides","slug":"peptides","term_group":0,"term_taxonomy_id":212,"taxonomy":"post_tag","description":"","parent":0,"count":5,"filter":"raw"},{"term_id":23,"name":"research peptides","slug":"research-peptides","term_group":0,"term_taxonomy_id":23,"taxonomy":"post_tag","description":"","parent":0,"count":10,"filter":"raw"},{"term_id":208,"name":"Selank","slug":"selank","term_group":0,"term_taxonomy_id":208,"taxonomy":"post_tag","description":"","parent":0,"count":1,"filter":"raw"},{"term_id":210,"name":"tuftsin","slug":"tuftsin","term_group":0,"term_taxonomy_id":210,"taxonomy":"post_tag","description":"","parent":0,"count":1,"filter":"raw"}],"_links":{"self":[{"href":"https:\/\/titanbornlabs.com\/index.php?rest_route=\/wp\/v2\/posts\/487","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/titanbornlabs.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/titanbornlabs.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/titanbornlabs.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/titanbornlabs.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=487"}],"version-history":[{"count":2,"href":"https:\/\/titanbornlabs.com\/index.php?rest_route=\/wp\/v2\/posts\/487\/revisions"}],"predecessor-version":[{"id":490,"href":"https:\/\/titanbornlabs.com\/index.php?rest_route=\/wp\/v2\/posts\/487\/revisions\/490"}],"wp:attachment":[{"href":"https:\/\/titanbornlabs.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=487"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/titanbornlabs.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=487"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/titanbornlabs.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}